StockData

CareTrust REIT vs National Healthcare Properties

CTRE and NHP side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CTRE and NHP compare

CareTrust REIT is the larger company, worth 7.8 times as much as National Healthcare Properties ($8.6B against $1.1B).

CareTrust REIT grew revenue faster over the last twelve months (53.0% versus −1.2% for National Healthcare Properties).

Both pay dividends: CareTrust REIT yields 4.1% and National Healthcare Properties 0.99%.

CareTrust REIT scores higher on the StockData Score (15 against 4 for National Healthcare Properties), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCTRENHP
Size and price
Market cap$8.6B$1.1B
Share price$36.39$15.08
Change, 1 year7.1%–
Change, 5 years72.5%–
Beta (5Y)0.52–
Employees4331
StockData Score
Total score15 (better)4
Valuation score22
Growth score4 (better)1
Performance score4 (better)0
Health score1 (better)0
Dividend score4 (better)1
Valuation
P/E22.9×–
P/S15.0×3.2× (better)
P/B1.9×1.0× (better)
EV/EBITDA16.2×10.4× (better)
Fair value$32.95$15.73
Margin of safety−10.4%4.2% (better)
Growth
Revenue growth (TTM)53.0% (better)−1.2%
Revenue growth, 5Y average21.7% (better)−2.2%
Net income growth (TTM)61.6%–
EPS growth (TTM)32.5%–
EPS growth, 5Y average13.1%–
Profitability
Gross margin–37.9%
Operating margin–3.2%
Net margin62.2%–
Return on equity9.1%–
Return on invested capital–1.3%
Financial health
Interest coverage–0.2×
Altman Z-score3.74 (better)0.91
Piotroski F-score5–
Dividends and buybacks
Dividend yield4.1% (better)0.99%
Payout ratio85.9%–
Years of dividend growth11–
Dividend growth, 5Y average6.0%–
Buyback yield−13.8%–
Shareholder yield−9.7%0.99% (better)
Ownership
Held by institutions106%72.9%
Held by insiders0.99%0.35%
Short interest, % of float4.7%4.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.